Ironwood Pharmaceuticals Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Ironwood Pharmaceuticals Stock Summary

Ironwood Pharmaceuticals competes with Neurocrine Biosciences, Amphastar, Collegium Pharmaceutical, ANI Pharmaceuticals, and Alkermes Plc. Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal products. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts. Ironwood Pharmaceuti operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 219 people.

Ironwood Pharmaceuticals Key Financial Ratios

Ironwood Pharmaceuticals Key Balance Sheet Accounts

Ironwood Pharmaceuticals Key Income Statement Accounts

Ironwood Pharmaceuticals Key Cash Accounts

Ironwood Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Ironwood Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Ironwood Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ironwood Pharmaceuticals competition to find correlations between indicators driving Ironwood Pharmaceuticals's intrinsic value. More Info.Ironwood Pharmaceuticals is rated below average in return on equity category among its peers. It is currently regarded as number one stock in return on asset category among its peers . At present, Ironwood Pharmaceuticals' Return On Equity is projected to slightly grow based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Ironwood Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Ironwood Pharmaceuticals Systematic Risk

Today, most investors in Ironwood Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Ironwood Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Ironwood Pharmaceuticals growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Ironwood Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ironwood Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ironwood Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Ironwood Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ironwood Pharmaceuticals's daily price indicators and compare them against related drivers.

When running Ironwood Pharmaceuticals' price analysis, check to measure Ironwood Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ironwood Pharmaceuticals is operating at the current time. Most of Ironwood Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ironwood Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ironwood Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ironwood Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.